Authors: KNORR B LARSON P CHERVINSKY P BLAKE K REISS T ROGERS J AMIN R NGUYEN H SEIDENBERG B SPIELBERG S

Citation: B. Knorr et al., SELECTION OF A MONTELUKAST DOSE IN 6 TO 14-YEAR-OLDS BY A COMPARISON OF PEDIATRIC AND ADULT SINGLE-DOSE PHARMACOKINETIC (PK) PROFILES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 73-73

Authors: KNORR B NGUYEN H VILLARAN C KEARNS G BOZA M ROGERS J REISS T SPIELBERG S

Citation: B. Knorr et al., SELECTION OF A MONTELUKAST DOSE IN 2 TO 5-YEAR-OLDS BY A COMPARISON OF PEDIATRIC AND ADULT SINGLE-DOSE POPULATION PHARMACOKINETIC (PK) PROFILES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 74-74

Authors: SPIELBERG S MCCREA J CRIBB A RUSHMORE T WALDMAN S BJORNSSON T LO MW GOLDBERG M

Citation: S. Spielberg et al., A MUTATION IN CYP2C9 IS RESPONSIBLE FOR DECREASED METABOLISM OF LOSARTAN, Clinical pharmacology and therapeutics, 59(2), 1996, p.

Authors: PASCAL M SPIELBERG S

Citation: M. Pascal et S. Spielberg, WHY I MADE 'SCHINDLERS LIST' - AN INTERVIEW WITH SPIELBERG,STEVEN, Queen's quarterly, 101(1), 1994, pp. 27-47